Evidence map›Paper›PMID 30276364›Full record

ArticleChronic diseases and translational medicine2018

Fine particulate matter (PM

Tao Li, Rong Hu, Zi Chen, Qiyuan Li, Shouxiong Huang, Zhou Zhu, Lin-Fu Zhou

Open access · goldAbstract read
In one paragraph

Article in Chronic diseases and translational medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 2 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 2 syntheses or guidelines pooled it, 167 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Health effects of air pollution on chronic respiratory diseases.The Korean journal of internal medicine · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Air Pollutants in Puerto Rico: Key Pollutants and Carcinogenic Properties.International journal of environmental research and public health · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Tao LiDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Rong HuDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Zi ChenDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Qiyuan LiDepartment of Translational Medicine, Medical College of Xiamen University, Xiamen, Fujian 361102, China.
Shouxiong HuangDepartment of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH 45249, USA.
Zhou ZhuSection of Allergy and Clinical Immunology, Internal Medicine and Pediatrics, Yale University School of Medicine, New Haven, CT 06511, USA.
Lin-Fu ZhouDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Nanjing Medical University · CNYale University · USUniversity of Cincinnati Medical Center · USXiamen University · CN

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI PINNEY, SUSAN MENGEL · 1992 to 2022
$35.4M
Treating lung inflammation by targeting SiglecsP01HL107151 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SCHNAAR, RONALD L · 2011 to 2017
$15.4M
Antigen metabolomics for mucosal-associated invariant T cells in tuberculosisR21AI115358 · NIAID · UNIVERSITY OF CINCINNATI · PI HUANG, SHOUXIONG · 2015 to 2016
$435k
NHLBI NIH HHS P01 HL107151NIAID NIH HHS R21 AI115358NIEHS NIH HHS P30 ES006096
6 · The paper itself

Abstract

Air pollution is a world public health problem. Particulate matter (PM), a mix of solid and liquid particles in the air, becomes an increasing concern in the social and economic development of China. For decades, epidemiological studies have confirmed the association between fine particle pollutants and respiratory diseases. It has been reported in different populations that increased Fine particulate matter (PM

Indexed as

Air pollutionChronic obstructive pulmonary diseaseLung diseasesParticulate matter

Identifiers

PMID30276364
PMCPMC6160608
OpenAlexW2889077654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.